Kaleido Biosciences, Inc.
KLDO
$0.002
$0.00191,900.00%
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.47M | 55.66M | 71.98M | 92.36M | 46.22M |
| Total Receivables | 934.00K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.65M | 2.65M | 2.62M | 2.67M | 2.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 254.00K | -- | -- | -- | -- |
| Total Current Assets | 42.31M | 58.30M | 74.60M | 95.03M | 48.72M |
|
|
|||||
| Total Current Assets | 42.31M | 58.30M | 74.60M | 95.03M | 48.72M |
| Net Property, Plant & Equipment | 5.67M | 7.34M | 7.53M | 7.83M | 8.46M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.16M | 2.16M | 2.16M | 2.16M | 2.16M |
| Total Assets | 50.14M | 67.80M | 84.29M | 105.03M | 59.34M |
|
|
|||||
| Total Accounts Payable | 5.67M | 3.56M | 2.70M | 2.41M | 5.39M |
| Total Accrued Expenses | 6.69M | 8.68M | 5.01M | 4.40M | 7.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.14M | 6.38M | 3.67M | 4.76M | 2.63M |
| Total Finance Division Other Current Liabilities | 1.18M | 637.00K | 893.00K | 1.30M | 1.28M |
| Total Other Current Liabilities | 1.18M | 637.00K | 893.00K | 1.30M | 1.28M |
| Total Current Liabilities | 29.68M | 19.26M | 12.27M | 12.87M | 16.66M |
|
|
|||||
| Total Current Liabilities | 29.68M | 19.26M | 12.27M | 12.87M | 16.66M |
| Long-Term Debt | 5.55M | 15.13M | 17.68M | 16.43M | 18.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.30M | 4.21M | 4.08M | 3.95M | 3.81M |
| Total Liabilities | 39.53M | 38.60M | 34.02M | 33.25M | 38.85M |
|
|
|||||
| Common Stock & APIC | 375.07M | 373.40M | 371.38M | 369.00M | 294.68M |
| Retained Earnings | -364.47M | -344.20M | -321.11M | -297.22M | -274.18M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.61M | 29.20M | 50.27M | 71.77M | 20.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.61M | 29.20M | 50.27M | 71.77M | 20.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.61M | 29.20M | 50.27M | 71.77M | 20.50M |
|
|
|||||